Huntington Beach, California and Amsterdam (ots/PRNewswire) - Agendia, a world leader in molecular cancer diagnostics, today announced the appointment of Dr. Albert A. (Al) Luderer to its Supervisory Board. Dr. Luderer has more than 30 years of experience in in vitro medical diagnostics, laboratory medicine and therapeutic development. Currently, he is the Chief ...
Huntington Beach, California, and Amsterdam (ots/PRNewswire) -- - Findings Published in Peer-Reviewed Journal, Breast Cancer Research and Treatment Agendia, a world leader in molecular cancer diagnostics, today announced that a study demonstrating the direct predictive ability of its breast cancer recurrence test, MammaPrint(R), has been published in Breast ...
Huntington Beach, California and Amsterdam (ots/PRNewswire) -- Agendia, a world leader in molecular cancer diagnostics, today announced that its signature breast cancer test MammaPrint(R) will be offered as standard of care for all eligible early stage breast cancer patients at the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL). The ...
Huntington Beach, California, and Amsterdam (ots/PRNewswire) -- Agendia, a world leader in molecular cancer diagnostics, today announced the appointment of Kurt Schmidt, CPA, MBA, as the company's new Chief Financial Officer. "Kurt is an exceptional addition to our team and an invaluable asset," said Bernhard Sixt, Ph.D., President and Chief Executive Officer. "With his extensive financial management experience ...